RNU6-68P

Across TCGA pan-cancer cohorts, RNU6-68P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU6-68P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RNU6-68P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-68P expression acts as an unfavorable survival marker.

LIHC, THCA, and OV are the cancer types where RNU6-68P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.059	0.777	<.001	108	view →
THCA	OS	Tertile	All	0.677	0.944	<.001	90	view →
OV	OS	Tertile	IV	0.053	0.772	<.001	72	view →
READ	DFS	Tertile	All	0.143	0.824	<.001	72	view →
COAD	OS	Tertile	II,III,IV	0.162	0.602	.014	63	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
UCEC	DFS	Tertile	All	0.100	0.646	.024	36	view →
KIRP	OS	Tertile	All	0.199	0.903	<.001	27	view →
BLCA	DFS	Tertile	All	0.186	0.597	.024	18	view →
LUSC	OS	Tertile	All	0.131	0.762	<.001	18	view →
MESO	DFS	Tertile	III,IV	0.168	0.418	.041	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNU6-68P–LIHC (OS)

Open the LIHC breakdown →